900 CHESAPEAKE DRIVE, REDWOOD CITY, CA
Lease Agreement Amendment - Bolt Biotherapeutics Enters Second Amendment
Reports Second Quarter 2026 Financial Results and Provides Business Update
2026 Annual Meeting Results; Director Nominees Elected at Bolt Biotherapeutics
Reports First Quarter 2026 Financial Results and Provides Business Update
Annual Report to Security Holders
Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update
Reports Third Quarter 2025 Financial Results and Provides Business Update
Provides Update on BDC-4182 and Extends Cash Runway into 2027
Q2
Q1
FY 2025
Q3
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Submission Upload
Correspondence
S-1MEF
SEC Staff Correspondence